A study published in Critical Care found that switching sedation from midazolam to dexmedetomidine in critically ill patients led to earlier recovery, faster extubation, and a significant reduction in delirium. For healthcare professionals, this supports guideline recommendations and suggests a tangible benefit for patients even when initial sedation deviates from best practices. The implication is a potential shift in clinical inertia regarding sedation adjustments in ICUs.
Read the full article at Blog Archives - Pharmacy Joe
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



